BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27462919)

  • 1. Genetic variations in apoptosis pathway and the risk of ovarian cancer.
    Xie H; Tao W; Wu X; Gu J
    Oncotarget; 2016 Aug; 7(35):56737-56745. PubMed ID: 27462919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in base excision repair pathway and risk of bladder cancer: a case-control study in the United States.
    Xie H; Gong Y; Dai J; Wu X; Gu J
    Mol Carcinog; 2015 Jan; 54(1):50-7. PubMed ID: 24038406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.
    Liang D; Meyer L; Chang DW; Lin J; Pu X; Ye Y; Gu J; Wu X; Lu K
    Cancer Res; 2010 Dec; 70(23):9765-76. PubMed ID: 21118967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in TGF-β pathway are associated with ovarian cancer risk.
    Yin J; Lu K; Lin J; Wu L; Hildebrandt MA; Chang DW; Meyer L; Wu X; Liang D
    PLoS One; 2011; 6(9):e25559. PubMed ID: 21984931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.
    Sun Y; Tao W; Huang M; Wu X; Gu J
    J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
    Wu X; Gu J; Grossman HB; Amos CI; Etzel C; Huang M; Zhang Q; Millikan RE; Lerner S; Dinney CP; Spitz MR
    Am J Hum Genet; 2006 Mar; 78(3):464-79. PubMed ID: 16465622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
    Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
    Xing J; Dinney CP; Shete S; Huang M; Hildebrandt MA; Chen Z; Gu J
    Cancer; 2012 Jan; 118(1):205-15. PubMed ID: 21692063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.
    Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B
    Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
    Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
    Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
    Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
    Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.
    Ye Y; Wang KK; Gu J; Yang H; Lin J; Ajani JA; Wu X
    Cancer Prev Res (Phila); 2008 Nov; 1(6):460-9. PubMed ID: 19138993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.
    Wang Y; Ye Y; Lin J; Meyer L; Wu X; Lu K; Liang D
    Mol Carcinog; 2015 Jun; 54(6):430-9. PubMed ID: 25867973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk.
    Barry KH; Koutros S; Andreotti G; Sandler DP; Burdette LA; Yeager M; Beane Freeman LE; Lubin JH; Ma X; Zheng T; Alavanja MC; Berndt SI
    Carcinogenesis; 2012 Feb; 33(2):331-7. PubMed ID: 22102698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.
    Pan J; Lin J; Izzo JG; Liu Y; Xing J; Huang M; Ajani JA; Wu X
    Carcinogenesis; 2009 May; 30(5):785-92. PubMed ID: 19270000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer.
    Lu ZH; Gu XJ; Shi KZ; Li X; Chen DD; Chen L
    J Formos Med Assoc; 2016 Jan; 115(1):31-7. PubMed ID: 25659662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
    Quaye L; Tyrer J; Ramus SJ; Song H; Wozniak E; DiCioccio RA; McGuire V; Høgdall E; Høgdall C; Blaakaer J; Goode EL; Schildkraut JM; Easton DF; Krüger-Kjaer S; Whittemore AS; Gayther SA; Pharoah PD
    PLoS One; 2009 Jun; 4(6):e5983. PubMed ID: 19543528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.
    Pearce CL; Near AM; Van Den Berg DJ; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Anderson AR; Edlund CK; Wu AH; Chen X; Beesley J; Webb PM; Holt SK; Chen C; Doherty JA; Rossing MA; Whittemore AS; McGuire V; DiCioccio RA; Goodman MT; Lurie G; Carney ME; Wilkens LR; Ness RB; Moysich KB; Edwards R; Jennison E; Kjaer SK; Hogdall E; Hogdall CK; Goode EL; Sellers TA; Vierkant RA; Cunningham JM; Schildkraut JM; Berchuck A; Moorman PG; Iversen ES; Cramer DW; Terry KL; Vitonis AF; Titus-Ernstoff L; Song H; Pharoah PD; Spurdle AB; Anton-Culver H; Ziogas A; Brewster W; Galitovskiy V; Chenevix-Trench G; ;
    Br J Cancer; 2009 Jan; 100(2):412-20. PubMed ID: 19127255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The VDR gene FokI polymorphism and ovarian cancer risk.
    Xu H; Li S; Qiu JQ; Gao XL; Zhang P; Yang YX
    Tumour Biol; 2013 Dec; 34(6):3309-16. PubMed ID: 24078452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.